Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Johnson Controls Second Quarter Performance Comparison

Elaine Mendonca by Elaine Mendonca
January 30, 2024
in Breaking News
0
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Johnson Controls is projecting that its second-quarter organic revenue will remain relatively unchanged compared to the previous year. The company also expects its adjusted earnings per share (EPS) before special items to be in the range of $0.74 to $0.78, slightly lower than the estimated $0.78.

During the first quarter of 2024, Johnson Controls reported an adjusted EPS of $0.51, which met market expectations. This indicates a steady performance in line with projections.

In the second quarter of 2023, the company experienced a significant 13% growth in organic sales and a 19% increase in adjusted EPS, reaching $0.75. This demonstrates a strong performance compared to the previous year.

Considering the company’s performance in the corresponding quarters of 2024 and 2023, it provides valuable context for understanding its expectations for the second quarter of this year.

Johnson Controls International plc (JCI) Stock Prices Show Mixed Performance on January 30, 2024: Conduct Thorough Research and Analysis Before Investing

On January 30, 2024, Johnson Controls International plc (JCI) experienced a mixed performance in its stock prices. As of that date, JCI was trading in the middle of its 52-week range, indicating stability. However, it was below its 200-day simple moving average, suggesting a bearish sentiment. The price of JCI shares increased by $0.06 since the market last closed, representing a rise of 0.11%. The stock closed at $56.65. In pre-market trading, JCI experienced a drop of $1.24 in its stock price. Investors should conduct thorough research and analysis before making any investment decisions regarding JCI or any other stock.

JCI Stock Performance on January 30, 2024: Mixed Revenue Growth and Earnings Decline Analysis

Title: JCI Stock Performance on January 30, 2024: A Mixed Bag of Revenue Growth and Earnings Decline

Introduction:

On January 30, 2024, Johnson Controls International (JCI) witnessed a mixed performance in terms of its stock performance. This article will delve into JCI’s financial data, focusing on its revenue growth and earnings decline, to provide insights into the stock’s performance on January 30, 2024.

Total Revenue Growth:

JCI reported a total revenue of $26.79 billion for the past year, representing a 5.91% increase compared to the previous year. However, the total revenue remained flat in the fourth quarter of 2023, standing at $6.91 billion.

Net Income Performance:

JCI recorded a net income of $1.85 billion over the past year, reflecting a significant 20.69% increase compared to the previous year. However, similar to the total revenue, JCI’s net income remained flat in the fourth quarter of 2023, amounting to $549.00 million.

Earnings per Share Decline:

JCI’s EPS for the past year was reported at $2.69, indicating a substantial 22.83% increase compared to the previous year. However, JCI experienced a notable decline in EPS during the fourth quarter of 2023, with the figure dropping to $0.80.

Conclusion:

JCI’s stock performance on January 30, 2024, was characterized by a mixed bag of revenue growth and earnings decline. The lack of growth in the fourth quarter raised concerns among investors. Additionally, the decline in EPS during the same period may have further impacted investor sentiment. Investors and analysts will closely monitor JCI’s future financial reports to gauge the company’s ability to sustain revenue growth and improve its earnings performance.

Tags: JCI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Markets and money

Mixed Analyst Sentiments and Price Targets for SL Green Realty

Biotechnology Market Capitalization

CanFite Expands Licensing Agreement to Include Pancreatic Cancer Indication

Finance_Fiscal (2)

Morgan Stanley Analyst Upgrades Price Target for Regions Financial

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com